The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1371
ISSUE 1371
August 22, 2011
Issue 1371
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
In Brief: Cardiovascular Safety of Varenicline (Chantix)
August 22, 2011 (Issue: 1371)
Varenicline (Chantix), which has been associated with neuropsychiatric symptoms such as agitation, depressed mood, changes in behavior and suicidal ideation, appears to be the most effective drug available for treatment of tobacco dependence.1...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.